Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA.
about
Retroviral RNA dimerization and packaging: the what, how, when, where, and whyCloning and characterization of hIF2, a human homologue of bacterial translation initiation factor 2, and its interaction with HIV-1 matrixDestiny of Unspliced Retroviral RNA: Ribosome and/or Virion?Nuclear trafficking of retroviral RNAs and Gag proteins during late steps of replicationOrchestrating the Selection and Packaging of Genomic RNA by Retroviruses: An Ensemble of Viral and Host FactorsThe Life-Cycle of the HIV-1 Gag-RNA ComplexProbing the HIV-1 genomic RNA trafficking pathway and dimerization by genetic recombination and single virion analysesTranslation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells.Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.Expression of IMP1 enhances production of murine leukemia virus vector by facilitating viral genomic RNA packaging.The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging.Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus.Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidationMacromolecular requirements for abrogation of Fv-1 restriction by murine leukemia viruses.Molecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidationHIV-1 RNA dimerization: It takes two to tangoThe retrovirus RNA trafficking granule: from birth to maturity.Function of a retrotransposon nucleocapsid proteinInduction of mouse type-C virus by translational inhibitors: evidence for transcriptional derepression of a specific class of endogenous virus.Mechanisms of human immunodeficiency virus type 2 RNA packaging: efficient trans packaging and selection of RNA copackaging partners.Effect of polymerase mutations on packaging of primer tRNAPro during murine leukemia virus assemblyUnusual features in the nucleotide sequence of a cDNA clone derived from the common region of avian sarcoma virus messenger RNA.Ty3 nucleocapsid controls localization of particle assemblySelective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA.Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or by gamma irradiation.Virus-specific RNA synthesis in interferon-treated mouse cells productively infected with Moloney murine leukemia virus.Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin DSequence requirements for localization and packaging of Ty3 retroelement RNA.Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.Translational control of retroviruses.Abrogation of Fv-1 restriction by genome-deficient virions produced by a retrovirus packaging cell line.Translational readthrough of the murine leukemia virus gag gene amber codon does not require virus-induced alteration of tRNA.Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli.Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure.Metabolism of viral RNA in murine leukemia virus-infected cells; evidence for differential stability of viral message and virion precursor RNA.Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.Interactions of murine leukemia virus core components: characterization of reverse transcriptase packaged in the absence of 70S genomic RNA.mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers.Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA.
P2860
Q21131436-78E203BC-74DF-43AD-8D1E-CBDD5E304BF6Q22010464-48670DE3-7834-46EE-9236-7382338135D1Q22242227-FEB1414D-F201-4695-AAF9-E76FAC87E1B8Q27026209-4B42D840-B514-4493-A80F-B0945905340EQ28074165-E9AC4D4E-9625-4F2F-ADC1-D57D77CA8435Q28076985-652CA264-3422-45BD-8238-CF7B958D1A89Q28476297-B6DA4140-D946-4564-B783-DA84685B8120Q30968445-2FBB5301-6D4D-416A-B83C-14ADCD59F8AAQ33783618-5D114C3F-1448-4CDA-BB39-DF91F7611097Q33786927-0321B1EB-8498-4FF1-B133-75B320329B1BQ33805882-4CAB0D6E-2C19-45E1-9EAE-213FF5834B04Q33827534-A8AB67F6-9F6E-43D9-98D5-54B55D80AFA1Q33854807-2559D4E7-D9EE-4AB9-A4C1-E4A385773833Q33923012-34F587C8-83D7-4041-BE5A-BF435ABDECF8Q34062113-C4AA4142-62BC-4CBD-9721-8D91FF02CCC8Q34666010-8E8FE4A3-FBEF-41FD-814B-66386109E1D4Q34667412-AC1FFDA4-37E6-47F6-9EA9-65962B77EA67Q34775636-FF340ACE-A6EE-4577-9005-7A9F79506898Q35043136-64D910FD-9A98-4FF3-8C38-3729C4CE63B4Q35140343-D3052C59-38F6-4911-8E76-3187DC8CD66EQ35237462-348FC243-646B-4EF0-A289-E9419EE4BBE7Q36350813-D281A852-8C9A-4D5E-8C82-C3A013524FD9Q36483898-636DC84C-4565-4F10-9906-1747E62F3E5EQ36491679-6DF9D566-431E-4856-AB72-3946B2FD4655Q36519877-830ADA1B-A842-47F1-A4EE-0A1E8B86D605Q36523364-49F3CB5C-CCA0-4ED2-BE7D-A15D26AC5F9EQ36546839-25CCA9D1-E994-4A9A-A63C-26CF973D3B39Q36626099-26922D12-808E-4D97-86D2-DFC2E65F5BD7Q36634241-A184CFD0-5A4D-4997-BFCA-7A14BB9EA49EQ36649979-8A280D81-DA83-4046-A7DB-5C2AABA400F0Q36708965-A3529176-F528-4F0B-AC74-E55340524342Q36810468-4430AFE9-4943-4737-A9F3-CD5FA7738E92Q36827747-A33391F5-3C6F-41B0-9E64-B2CC66B0B59EQ36883944-FBAFDBDF-E4E1-40E7-86FB-69AC4F9C865FQ36893803-2F0B4AF1-F5BF-4AD5-A66B-1C35F659E5F9Q36935270-A5ADEA62-215E-47D7-BA2A-B119BEC64B47Q37131965-8E47F2AC-EFA8-47BB-A384-549031ED3174Q37507683-5F1FB109-5561-4CAB-8AAC-08ED4E3C21CAQ37568355-C9B3E422-635E-4E22-8CA9-1F54E880F61CQ37594301-11FEFC8B-8D68-4FEC-9E77-8E78FC7B5FE1
P2860
Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA.
description
1976 nî lūn-bûn
@nan
1976 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@ast
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@en
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@nl
type
label
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@ast
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@en
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@nl
prefLabel
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@ast
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@en
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@nl
P2860
P356
P1476
Synthesis of murine leukemia v ...... stence of viral messenger RNA.
@en
P2093
P2860
P304
P356
10.1073/PNAS.73.4.1154
P407
P577
1976-04-01T00:00:00Z